Santon Drugs Rpivate Limited - Company Profile

It is a chemicals private limited company based in Kolkata, West Bengal, India, established in 2010.
2010 Kolkata, West Bengal, India Struck Off
Last Updated:
Access Report
About Santon Drugs Rpivate Limited

Santon Drugs Rpivate Limited, a struck off private limited company, was established on 02 November 2010 in Kolkata, West Bengal, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24200WB2010PTC154424. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.21 M.

Its leadership includes Shankar Saha (Director), Sumita Saha (Director), Debmalya Saha (Director). Its latest AGM occurred on 28 September 2012, with the balance sheet filed on 31 March 2012. It is based at 34, Chittaranjan Avenue Jaba Kusum Building, 2Nd Floor, Room No., -4, Kolkata, West Bengal, 700072.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24200WB2010PTC154424

  • Registration Number

    154424

  • Incorporation Date

    02 November 2010

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.21 M

  • ROC Code

    Roc Kolkata

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.21 M
  • Company Age 15 Year, 3 Months
  • Last Filing with ROC 31 Mar 2012
Company report

Santon Drugs Rpivate Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Santon Drugs Rpivate Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Santon Drugs Rpivate Limited?
Current Directors
Name Designation Appointment Date Status
Shankar Saha Director 02 Nov 2010 Current
Sumita Saha Director 02 Nov 2010 Current
Debmalya Saha Director 02 Nov 2010 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Santon Drugs Rpivate.

Enhance accessibility to Santon Drugs Rpivate's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Santon Drugs Rpivate revenue growth over time
Santon Drugs Rpivate profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Santon Drugs Rpivate?

Unlock access to Santon Drugs Rpivate's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Santon Drugs Rpivate?

Unlock and access historical data on people associated with Santon Drugs Rpivate, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Santon Drugs Rpivate, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Santon Drugs Rpivate's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Santon Drugs Rpivate
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Santon Drugs Rpivate Limited last Annual general meeting of members was held on 28 Sep 2012 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Santon Drugs Rpivate Limited has filed its annual Financial statements for the year ended 31 Mar 2012 with Roc Kolkata. was completed.

  • Director Appointment

    The activity Shankar Saha was appointed as a Director was appointed as a Director on 02 Nov 2010 & has been associated with this company since 15 years 3 months . was completed.

  • Director Appointment

    Sumita Saha was appointed as a Director was appointed as a Director on 02 Nov 2010 & has been associated with this company since 15 years 3 months . was recorded as a recent event.

  • Director Appointment

    The activity Debmalya Saha was appointed as a Director was appointed as a Director on 02 Nov 2010 & has been associated with this company since 15 years 3 months . was completed.

  • Company Incorporation

    The activity Santon Drugs Rpivate Limited was registered on 02 Nov 2010 with Roc Kolkata & aged 15 years 3 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Santon Drugs Rpivate Limited?

The CIN of Santon Drugs Rpivate Limited is U24200WB2010PTC154424.

Where is Santon Drugs Rpivate Limited headquartered?

Santon Drugs Rpivate Limited is headquartered at 34, Chittaranjan Avenue Jaba Kusum Building, 2Nd Floor, Room No., -4, Kolkata, West Bengal, 700072.

When was Santon Drugs Rpivate Limited incorporated?

Santon Drugs Rpivate Limited was incorporated on 02 November 2010.

Who are the current directors of Santon Drugs Rpivate Limited?

The current directors of Santon Drugs Rpivate Limited are

What is the primary industry of Santon Drugs Rpivate Limited?

The primary industry of Santon Drugs Rpivate Limited is Chemicals.

Is Santon Drugs Rpivate Limited a listed company?

Santon Drugs Rpivate Limited is unlisted.

What is the capital structure of Santon Drugs Rpivate Limited?

The authorized capital of Santon Drugs Rpivate Limited is ₹1.00 M, and the paid-up capital is ₹0.21 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available